News

Analytik Jena Announces Sales and Earnings Forecast for the 2010/2011 Financial Year

19.04.2011 | Nouveautés

Jena, April 19, 2011 — Analytik Jena AG (Frankfurt DE0005213508, Prime Standard: AJA) expects sales for the ongoing 2010/2011 financial year to be between approximately EUR 86.0 m and EUR 89.0 m, i.e. another significant sales growth compared with the previous year. This was announced today by the Thuringia-based manufacturer of analytical instrumentation in the run-up to its 11th Annual General Meeting in Jena. In the 2009/2010 financial year, the Company generated consolidated sales of EUR 80.2 m.

The reason for the broad range quoted in connection with the expected figures is the fact that it is currently impossible to estimate the effects of the natural disaster in Japan and its consequences on business performance.

Analytik Jena also expects operating earnings to increase over the previous year. In total, the Company expects EBIT to range between EUR 4.5 m and EUR 5.5 m (previous year EUR 3.1 m). As such, CEO Klaus Berka re-affirms his growth strategy and the intention of pursuing Analytik Jena’s earnings-oriented path.

"In the current financial year, we have once again set ourselves ambitious sales and earnings targets and expect our positive business performance to continue," commented Klaus Berka. "In view of recent developments in Japan, however, it is already clear that we will not achieve our goals there. We are currently in close contact with our employees in Japan in order to support them in overcoming the effects of the natural disaster in their region."

Accordingly, the Company intends to provide extensive assistance in the affected region, by supplying equipment worth approximately EUR 50,000 for environmental and food analysis as well as prevention of infectious diseases. In addition, the subsidiary’s employees in the affected regions are to re-commission and/or repair equipment free of charge.

At present, the Company still expects the overall economic recovery on the global markets to continue and that demand will continue to grow in the Analytical Instrumentation and Life Science divisions. Analytik Jena also expects sales of opto-electrical consumer products to increase.

Following an excellent start to the 2010/11 financial year, the Company achieved sales of almost EUR 45.0 m in the first six months (previous year: EUR 40.8 m). With respect to operating earnings (EBIT), the Company does not expect to reach the previous year’s level, particularly as a result of the current sales situation in Japan and despite ending the second quarter positively. The greatest challenge in this financial year will be to compensate for the losses in Japan and to absorb the effects of the weak US dollar. Approximately 30.0% of sales are generated in the US dollar currency zone.

The Company is set to announce the complete figures for the second quarter and for the first six months of 2010/2011 on May 12, 2011.

At today’s Annual General Meeting, the Executive Board and the Supervisory Board will propose distributing a dividend of EUR 0.15 per share. This would be the Company’s first dividend payment since its IPO in 2000.


Contact

Hanna Engelhardt
Media Relations Life Science
+49 (0) 36 41  77-73 55press@laboservices.tn

The newsletter of Analytik Jena frequently keeps you posted about:

Sign up here